Quantcast
Home / News / $121.5 million awarded for ‘triple malpractice’

$121.5 million awarded for ‘triple malpractice’

In a rare case of “triple malpractice,” a jury awarded $121.5 million against three hospitals that treated a patient during a one-month period, which began with an office visit for seizure medication, progressed to a severe allergic skin reaction and ended with brain damage caused by lack of oxygen.
Scroll To Top